Fraunhofer Gesellschaft is Europe's largest society for applied research (67 institutes in Germany, 23.000 employees) and conducts applied research in collaboration with industry partners. Fraunhofer IZI (600 employees, 4 locations in Germany, 2 international locations) is focusing on applied research in biomedicine and conducts applied research projects in the four business areas "cell and gene therapies", "drugs", "diagnostics" and "biosystems technology".
McMaster University and the Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer IZI) established a joint project centre in Hamilton in 2014 to develop novel technologies for cell therapy and point-of-care diagnostics.
FPC-BEAM brings together expertise from both the Fraunhofer IZI (Europe’s Leader in Cell Therapy Manufacturing) and McMaster University (2017 Most Research Intensive University) to create a unique institute with a core focus on applied research. Leveraging McMaster’s research expertise and Fraunhofer’s proven ability to translate research to industry, FPC-BEAM will allow academic and industry partners to translate their ideas into commercially viable products.
Fraunhofer’s facilities and network in Europe will effectively broaden the global impact of BEAM by providing an avenue for delivery of BEAM products to the European market as well as help to attract European companies to Southern Ontario.